# A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis

> **NCT03544229** · PHASE2 · COMPLETED · sponsor: **Millennium Pharmaceuticals, Inc.** · enrollment: 242 (actual)

## Conditions studied

- Diabetic Gastroparesis
- Idiopathic Gastroparesis

## Interventions

- **DRUG:** TAK-906 Maleate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03544229
- **Lead sponsor:** Millennium Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-14
- **Primary completion:** 2021-06-14
- **Final completion:** 2021-07-15
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2022-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03544229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03544229, "A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03544229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*